Pfizer Consumer Health Is “Logical Extension” Of Rx – CEO McKinnell
This article was originally published in The Tan Sheet
Executive Summary
Pfizer is emphasizing the strategic importance of its OTC business for patent-expired Rx products as the firm nears the period when it could divest any of its businesses following the Warner-Lambert merger
You may also be interested in...
Warner-Lambert
First-year sales of Cool Mint Listerine PocketPaks strips, which launched nationwide Oct. 9, expected to exceed $100 mil., company says. W-L and ad agency J. Walter Thompson (New York) plan to launch $40 mil. campaign including TV, other mediums within next few weeks (1"The Tan Sheet" July 9, p. 4). PocketPaks, which kill odor-causing mouth germs, received promotional support from network TV's Regis & Kelly show when exuberant co-host Kelly Ripa tried strips on air and gave them an enthusiastic review. Over the last few months, W-L has sent free samples to several TV stations, professional sports teams and modeling agencies across the country, firm says
OTC Sale Of Rx Allergy Drugs Would Be Safer, Cut Costs - Health Plan
Nonsedating antihistamines classified as prescription drugs would be more appropriately sold as OTCs, Blue Cross of California Pharmacy VP Rob Seidman maintains in Jan. 12 letters sent to marketers of the drugs.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC